Not overly bullish on healthcare as a whole, as its growth may be less attractive. Likes medical devices, with a built-in backlog due to Covid. He owns SYK. There should be a significant pickup in procedures over the next 2 years. SYK has strong earnings growth, near a 1-year high. Also look at IHI, the medical devices ETF, packed with companies leading the healthcare sector.
(A Top Pick Aug 15/18, Up 20%) A good way to play pharma without the litigation problems. For a Canadian one, it would be ZUH. Medical devices have done very well, and wish he had more.
ISHARES DOW JONES US MEDICAL DEV.(ETF) is a American stock, trading under the symbol IHI-N on the NYSE Arca (IHI). It is usually referred to as AMEX:IHI or IHI-N
In the last year, 1 stock analyst published opinions about IHI-N. 1 analyst recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for ISHARES DOW JONES US MEDICAL DEV.(ETF).
ISHARES DOW JONES US MEDICAL DEV.(ETF) was recommended as a Top Pick by on . Read the latest stock experts ratings for ISHARES DOW JONES US MEDICAL DEV.(ETF).
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
1 stock analyst on Stockchase covered ISHARES DOW JONES US MEDICAL DEV.(ETF) In the last year. It is a trending stock that is worth watching.
On 2023-06-05, ISHARES DOW JONES US MEDICAL DEV.(ETF) (IHI-N) stock closed at a price of $54.11.